The association of chemotherapy and radiotherapy: Biological rationale

Current Drug Therapy

Volumn 5, Issue 3, 2010, Pages 152-156

  Danesi, Donatella Tirindelli ^a  

^a ENEA C R CASACCIA   (Italy)

Author keywords

5 fluouracil; Epidermal growth factor inhibitors; Epigenetic gene expression modulators; Gemcitabine; Platinum; Radiation sensitizers; Radiochemotherapy biological rationale; Taxol

Indexed keywords

CAPECITABINE; CETUXIMAB; CISPLATIN; CYTOTOXIC AGENT; DNA; DNA METHYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUOROPYRIMIDINE; FLUOROURACIL; GEFITINIB; GEMCITABINE; OXALIPLATIN; PACLITAXEL; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CYCLE; CELL STRESS; CELL SURVIVAL; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; EPIGENETICS; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; IONIZING RADIATION; IRRADIATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

EID: 78649279420     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488510791561101     Document Type: Article

References (28)

1. Steel GG, Peckam MJ. Exploitable mechanisms in combinedradiotherapy-chemotherapy: The concept of additivity. Int J RadiatOncol Biol Phys 1979; 5: 85-91.
2. Urtasun RC, Coleman CN, Wasserman TH, Phillips TL. Clinicaltrials with hypoxic cell sensitizers: Time to retranch or time to pushforward? Int J Radiat Oncol Biol Phys 1984; 10: 1691-1696.
3. Bagshaw MA. Possible role of potentiators in radiation therapy. Am J Roentgenol 1961; 85: 822-833.
4. Vietti T, Eggerding F, Valeriote F. Combined effect of X-radiationand 5-fluorouracil on survival of transplanted leukemic cells. J NatlCancer Inst 1971; 47: 865-870.
5. Nylen U, Cekan E, Jonasson GB, Lewin F, Skog S. Effects of5-fluorouracil on cell cycle arrest and toxicity induced byX-irradiation in normal mammalian cells. Cell Prolif 2001; 34: 85-98.
6. Sawada N, Ishikawa T, Sekiguchi F, et al. X-ray irradiation inducesthymidine phosphorylase and enhances the efficacy of capecitabine(Xeloda) in human cancer xenografts. Clin Cancer Res 1999; 5:2948-2953.
7. Dewit L. Combined treatment of radiation and cis-diammine-dichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987; 13: 403-426.
8. Joschko MA, Webster LK, Bishop JF, et al. Radioenhancementby cisplatin with accelerated fractionated radiotherapy in a humantumour xenograft. Cancer Chemother Pharmacol 1997; 40: 534-539.
9. Tirindelli DD, Arcangeli G, Cruciani E, et al. Conservative treat-ment of invasive bladder cancer by transurethral resection, protrac-ted intravenous infusion chemotherapy and hyperfractionatedchemotherapy: long term results. Cancer 2004; 101: 2540-2548.
10. Cividalli A, Ceciarelli F, Lividi, E, et al. Radiosensitization byoxaliplatin in a mouse adenocarcinoma: influence of treatmentschedule. Int J Radiat Oncol Biol Phys 2002; 52: 1092-1098.
11. Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ.Role of reoxygenation in induction of enhancement of tumor radio-response by paclitaxel. Cancer Res 1995; 55: 3564-3568.
12. Cividalli A, Arcangeli G, Cruciani G, Livdi E, Cordelli E, TirindelliDD. Enhancement of radiation response by paclitaxel in mouse ac-cording to different treatment schedules. Int J Radiat Oncol BiolPhys 1998; 40: 1163-1170.
13. Cividalli A, Livdi E, Ceciarelli F, et al. Combined use of gemcit-abine and radiation in mice. Anticancer Res 2001; 21: 307-312.
14. Cividalli A, Mauro F, Livdi E, et al. Schedule dependent toxicityand efficacy of combined gemcitabine/paclitaxel treatment inmouse adenocarcinoma. J Cancer Res Clin Oncol 2000; 126: 461-467.
15. Wilson GD, Bentzen SM, Harari PM. Biological basis for combi-ning drugs with radiation. Semin Radiat Oncol 2006; 16:2-9.
16. Contessa JN, Reardon DB, Todd D, et al. The inducible expressionof dominant-negative epidermal growth factor receptor-CD533 re-sults in radiosensitization of human mammary carcinoma cells.Clin Cancer Res 1999; 5: 405-411.
17. Liang K, Ang KK, Milas L, Hunter N, Fan Z. The epidermalgrowth factor receptor mediates radioresistance. Int J Radiat OncolBiol Phys 2003; 57: 246-254.
18. Huang SM, Harari PM. Modulation of radiation response afterepidermal growth factor receptor blockade in squamous cell carci-nomas: Inhibition of damage repair, cell cycle kinetics, and tumorangiogenesis. Clin Cancer Res 2000; 6: 2166-2174.
19. Dittmann K, Mayer C, Fehrenbacher B, et al. Radiation-inducedepidermal growth factor receptor nuclear import is linked to activa-tion of DNA-dependent protein kinase. J Biol Chem 2005; 280:3182-3189.
20. Rodemann HP, Dittmann K, Toulany M. EGFR-signaling andcontrol of DNA-damage repair. Int J Radiat Biol 2007; 83: 781-791.
21. Meyn RE, Munshi A, Haymach JV, Milas L, Ang KK. Receptorsignaling as a regulatory mechanism of DNA repair. RadiotherOncol 2009; 92: 316-322.
22. Negroni A, Stronati L, Grollino MG, Barattini P, Gumiero D, Tirindelli DD. Radioresistance in a tumor cell line correlates withradiation inducible Ku 70/80 end-binding activity. Int J Radiat Biol 2008; 84: 265-276.
23. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximabfor squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
24. Baumann M, Krause M, Dikomey E, et al. EGFR-targeted antican-cer drugs in radiotherapy: Preclinical evaluation of mechanisms.Radiother Oncol 2007; 83: 238-248.
25. Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. Func-tional diversity of DNA methyl tranferase inhibitors in human can-cer cell lines. Cancer Res 2006; 66: 2794-2800.
26. Flatmark K, Nome RV, Folkyord S, et al. Radiosensitization ofcolorectal carcinoma cell lines by histone deacetylase inhibition. Radiat Oncol 2006; 3: 1-25.
27. Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: astrategy for tumor radiosensitization. J Clin Oncol 2007; 25: 4051-4056.
28. Advani Sj, Weichselbaum RR, Chmura SJ. Enhancing radiotherapywith genetically engineered viruses. J Clin Oncol 2007; 25: 4090-4095.